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Summary:
The PhysioFlow bioimpedance cardiography device provides key measures of central systolic and diastolic
and peripheral vascular function. Many of these variables have not been assessed for intrarater reliability
and agreement during rest, submaximal exercise and high-intensity interval exercise. Twenty healthy adults
(age: 26±4 years) completed two identical trials beginning with five minutes of rest followed by two 5-minute
submaximal cycling bouts at 50% and 70% of peak power output. Subjects then completed ten 30-second
cycling intervals at 90% of peak power output interspersed with 60 s of passive recovery. Bioimpedance
cardiography (PhysioFlow; Manatec Biomedical, France) monitored heart rate, stroke volume, cardiac output,
stroke volume index, cardiac index, ventricular ejection time, contractility index, ejection fraction, left
cardiac work index, end diastolic volume, early diastolic filling ratio, systemic vascular resistance and
systemic vascular resistance index continuously throughout both trials. Intraclass correlation coefficients
(ICC), standard errors of measurement and minimal detectable differences were calculated for all variables.
Heart rate, stroke volume, cardiac output, left cardiac work index and end diastolic volume demonstrated a
good level of reliability (ICC>.75) at rest, during submaximal exercise and high-intensity interval exercise.
All other variables demonstrated inconsistent reliability across activity types and intensities. When using
the PhysioFlow device, heart rate, stroke volume, cardiac output, left cardiac work index and end diastolic
volume were deemed acceptable for use regardless of exercise type (continuous vs. interval) or intensity (low,
moderate, or high). However, other variables measured by this device appear less reliable.
Key words: bioimpedance cardiography, exercise, reliability, high-intensity interval exercise, cardiac
output, minimal detectable differences, central haemodynamics, peripheral haemodynamics

Introduction

The ability to continuously measure haemodynamic responses to exercise is important when assessing or monitoring individuals before, during
and following acute and chronic exercise. For example, cardiac output has been used to determine
exercise tolerance and cardiac function during exercise (Crisafulli, Orru, Melis, Tocco, & Concu,
2003; Fletcher, et al., 2001) as well as during clinical responses to physiological and pharmacologi140

cal stimuli (Leitman, et al., 2006; Parry & McFetridge-Durdle, 2006; Richard, et al., 2001; Tahvanainen, Leskinen, Koskela, Ilveskoski, Nordhausen, et al., 2009). Several methods are available
for measuring cardiac output (see reviews: Sangkum, et al., 2016; Thiele, Bartels, & Gan, 2015;
Warburton, Haykowsky, Quinney, Humen, & Teo,
1999a, 1999b) during exercise, with the most common methods, based on the Fick principle, being
thermodilution and dye-dilution techniques. These
techniques are both accurate and reliable (Chris-
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tie, et al., 1987; Thrush, Downs, & Smith, 1995);
however, they are invasive and require experienced
technicians. The use of Doppler echocardiography
and rebreathing methods (Thiele, Bartels, & Gan,
2015) to measure cardiac output, while non-invasive, are themselves limited in use due to requiring
an experienced technician and not providing beatto-beat measurements, respectively (Jakovljevic, et
al., 2008; Oberman, et al., 1989).
Bioimpedance cardiography provides non-invasive, beat-to-beat measures of cardiac output without the need for highly skilled technicians; however, the validity and reliability of these devices
are equivocal (Saugel, Cecconi, Wagner, & Reuter, 2015; Thiele, Bartels, & Gan, 2015). It is likely
the reliance on the evaluation of baseline thoracic
impedance (Z0) provides a degree of error in measurement for most devices as Z0 depends on multiple factors (Bernstein, 1986; Jensen, Yakimets,
& Teo, 1995; Kubicek, Karnegis, Patterson, Witsoe, & Mattson, 1966; Penney, 1986). The PhysioFlow (Manatec Biomedical, France) provides
an alternative as it does not rely on the evaluation
of Z0 nor does it need to measure blood resistivity or the distance between electrodes, both which
introduce additional measurement error (Jensen,
Yakimets, & Teo, 1995; Warburton et al., 1999b).
Previous studies have assessed the validity of PhysioFlow to measure cardiac output during rest and
exercise against the direct Fick (Bougault, et al.,
2005; Charloux, et al., 2000; Richard, et al., 2001),
dye-dilution (Robach, et al., 2008) and rebreathing
methods (Tordi, Mourot, Matusheski, & Hughson,
2004). Specifically, when assessed against the gold
standard (i.e., direct Fick), the PhysioFlow has been
shown to provide accurate measures of cardiac output during rest and exercise (correlation coefficient
= 0.71-0.94, mean difference = 0.04-3.20 L·min-1)
(Bougault, et al., 2005; Charloux, et al., 2000; Richard, et al., 2001). Additionally, studies have reported
generally moderate to good reliability and agreement between repeated measures of cardiac output
during rest and exercise (Charloux, et al., 2000;
Hsu, et al., 2006; Richard, et al., 2001; Schultz,
Climie, Nikolic, Ahuja, & Sharman, 2012; Tordi,
Mourot, Matusheski, & Hughson, 2004; Welsman,
Bywater, Farr, Welford, & Armstrong, 2005). Another often overlooked measurement relevant to a
device’s applicability is the minimal detectable difference (MDD). This measurement is defined as the
smallest change detectable above the threshold of
measurement error (Beaten, et al., 2001; Portney &
Watkins, 2009) and provides an indication of the
sensitivity of a device to detect meaningful changes. Knowing the MDD of all PhysioFlow measurements will provide important information regarding
the ability of the PhysioFlow to detect differences
between populations and changes over time. We are
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unaware of any study to date which has examined
the reliability of the PhysioFlow during dynamic
non-steady-state exercise (i.e., high-intensity interval exercise) and this is important given this mode
of training is increasingly being prescribed to both
healthy and chronic disease populations (Gibala,
Little, Macdonald, & Hawley, 2012).
The majority of literature assessing the reliability of bioimpedance cardiography has focused on
the measurement of heart rate, stroke volume and
cardiac output. However, several other haemodynamic indices are provided, including variables relating to central systolic function (Leitman, et al.,
2006; Miles, Gotshall, Quinones, Wulfeck, & Kreitzer, 1990; van der Meer, et al., 1996), central diastolic function (Pickett & Buell, 1993) and peripheral vascular function (Leitman, et al., 2006). Evidence related to the validity and reliability of many
of these measures are lacking; however, the ability
to assess and monitor central systolic and diastolic function as well as peripheral vascular function
using one device in a variety of exercise conditions
would be cost- and time-efficient for researchers
and clinicians. As such, the purpose of this study
was to assess the intrarater reliability and agreement as well as to calculate the MDD of all variables
measured and calculated by the PhysioFlow at rest,
during submaximal steady-state exercise and highintensity interval exercise in a healthy population.

Methods
Subjects
Twenty healthy adults (15 males; age: 26±4
years; body mass index: 23.7±3.0 kg·m2) volunteered to participate in this study. Data from one
subject were excluded from analyses due to poor
signal quality during the interval section of the second trial, resulting in a total of 19 subjects included in the analyses. Subjects were excluded from
the study if they presented with a history of cardiovascular or metabolic disorders. Subjects were
required to attend the laboratory on three separate
occasions during which they performed a graded
exercise test and two experimental sessions. Each
session was separated by seven days. Subjects were
asked to avoid strenuous physical activity the day
before and the day of testing, with all testing completed at a similar time of day. All risks and benefits
of participating in the study were provided to the
subjects and written informed consent was obtained
prior to data collection. This study received ethical
approval from the Murdoch University Human Research Ethics Committee (2015/146) prior to commencement of the study and conformed to the Code
of Ethics of the World Medical Association (Declaration of Helsinki).
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Procedures
Subjects completed all trials on an electronically braked Velotron cycle ergometer (RacerMate;
USA) that was individually set up for each subject
and kept consistent throughout the study. During
the first visit, subjects completed a graded exercise
test starting at 70 W, and increased 35 W·min-1 for
males and 20 W·min-1 for females, until volitional
exhaustion. The volume of oxygen consumption and
carbon dioxide production were measured at 1Hz
and presented as 30-s mean values using a Parvo
TrueOne metabolic analysis system (ParvoMedics; USA). The highest 30 s mean value was used
to determine maximal oxygen consumption. The
maximum power output achieved during this test
was used to prescribe the intensity of exercise in
the remaining sessions.
The second and third testing sessions were completed in an identical manner and in an environmental chamber controlled at 24°C and 50% relative
humidity. Subjects arrived at the laboratory at least
3 h postprandial and in a euhydrated state. Hydration status was assessed using a hand-held refractometer (RHCN-200ATC Clinical Refractometer,
G-tech, China) prior to beginning each trial. Urine
specific gravity between 1.005-1.020 was classified
as euhydrated, whereas values greater than 1.020
indicated dehydration (Kavouras, 2002). Subjects
were informed that if they were not fasted or if presented as dehydrated, they were required to return
on another day for testing, but this did not occur.
Each session began with five minutes of passive rest
on the cycle ergometer followed by two 5-minute
submaximal cycling bouts at 50% (140±34 W) and
70% (196±48 W) of the maximum power output
achieved during the graded exercise test (286±66
W). Following one minute of passive recovery, subjects then completed ten 30-second cycling intervals
at 90% peak power output (252±62 W) interspersed
with 60 s of passive recovery. Our interval configuration is in line with previous research (Freyssin,
et al., 2012) and was chosen to elicit a physiological response high enough to be considered highintensity, but still allowing adequate rest between
intervals to minimise the effect of fatigue. Power
output throughout the trials was maintained using
Velotron cycling ergometer software.
The volume of oxygen consumed was measured
at 1 Hz using the ParvoMedics metabolic analysis system. Haemodynamic responses were measured beat-by-beat using bioimpedance cardiography
(PhysioFlow PF-07; Manatec Biomedical, France).
Blood pressure, obtained by manual sphygmomanometry during the fourth minute of the rest period and each submaximal cycling bout, were entered into the software to update the systemic vascular resistance (SVR), systemic vascular resistance
index (SVRi) and left cardiac work index (LCWi).
Blood pressure measures were not updated during
142
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the interval cycling section due to the lag time evident between entering a new blood pressure and
the adjustments observed in SVR, SVRi and LCWi;
instead, the values obtained during the 70% peak
power steady-state exercise were used for the determination of SVR, SVRi and LCWi during highintensity interval exercise. While this may influence
the validity of the data, it should have minimal influence on the reliability.
Impedance cardiograph measures
Continuous online haemodynamic monitoring
was completed using the PhysioFlow PF-07, which
uses changes in thoracic bioimpedance during cardiac ejection to calculate stroke volume. Detailed
methodology of the PhysioFlow device has been
described previously (Charloux, et al., 2000; Hsu,
et al., 2006; Lepretre, Koralsztein, & Billat, 2004;
Tonelli, Alnuaimat, Li, Carrie, & Mubarak, 2011).
Two sets of two electrodes (Ag/AgCl, Skintact FS50), one ‘transmitting’ and one ‘sensing’, were
placed above the supraclavicular fossa on the left
base of the neck and at the midpoint of the thoracic
region of the spine. Another set of two electrodes
were used to monitor a single electrocardiographic
signal (ECG; V1/V6 position). A high frequency alternating current (66 kHz) of low amperage (4.5 mA
peak to peak) was applied through the thorax producing an impedance waveform which was timecorrected to the simultaneous ECG recording. Since
Z0 evaluation is not required with the PhysioFlow
device, electrode positioning is not crucial (Tan,
Lai, & Hwang, 2006). Thorough skin preparation
(i.e., shaving, abrasion and alcohol wiping) was
completed to ensure effective conductivity between
the electrode and the skin.
An initial stroke volume index (SVical; mL.m2)
was calculated during the autocalibration phase
based on 30 consecutive heart beats with the subject sitting in an upright position on the cycle ergometer. During autocalibration, the largest impedance variation observed during systole (Zmax - Zmin)
and the largest rate of variation of the impedance
signal (contractility index; dZ/dtpeak) were retained.
The determination of SVical also depends on the
thoracic flow inversion time (TFIT), acquired from
the first mathematical derivative of the impedance
signal (dZ/dt), according to the following equation:
SVical = k ∙ [(dZ/dtmax) / (Zmax - Zmin)] ∙ W(TFITcal),
where k is an empirically adjusted constant and W
is a propriety correction algorithm. During the data
acquisition phase, stroke volume (SV; mL) was calculated according to the equation: SV = SVical ∙ ((dZ/
dtmax) / (dZ/dtmax)cal ∙ TFITcal ∙ TFIT)1/3 ∙ BSA, where
body surface area (BSA; m2) was calculated according to the Haycock equation (BSA = 0.024265
∙ height0.3964 ∙ weight0.5378) (Haycock, Schwartz, &
Wisotsky, 1978). Cardiac output (L∙min-1) was calculated using the following equation: CO = HR ∙

Gordon, N. et al.: INTRARATER RELIABILITY AND AGREEMENT OF THE...

SVi ∙ BSA, where heart rate (HR; bpm) was determined from the R-R interval on the first derivative of the ECG signal (dECG/t) as this provides a
more stable signal. Cardiac index (CI; L∙min-1∙m2)
was calculated as the ratio of CO to BSA. Ventricular ejection time (VET; ms) was measured from
the dZ/dt and was defined as the time between the
opening (B point) and closing (X point) of the aortic valve. Left ventricular ejection fraction (EF; %)
was calculated according the Capan equation (van
der Meer, et al., 1996): EF = 0.84 – (0.64 ∙ PEP) /
VET, where PEP is the pre-ejection period, defined
as the time between the onset of the Q wave of the
ECG and the B point. LCWi (kg∙m-1∙m2) was calculated according to the following equation: LCWi =
0.0144 ∙ CI ∙ (MAP - PAOP), where MAP (mmHg)
is the mean arterial pressure calculated from the
systolic and diastolic blood pressure entered by the
user, and PAOP is the pulmonary artery occlusion
pressure which was by default set as 10 mmHg during the calibration procedure. End diastolic volume
(EDV; mL) was calculated as the ratio of SV to EF.
The early diastolic filling ratio (EDFR) was measured on the dZ/dt and was defined as the ratio of
the O wave to the S wave. Systemic vascular resistance (Dyn∙s-1∙cm5) was calculated by the following
equation: SVR = 80 ∙ (MAP – CVP) / CO, where
CVP is the central venous pressure, which was by
default set as 7 mmHg during the calibration procedure. Systemic vascular resistance index (Dyn∙s1
∙cm5∙m2) was calculated by the following equation:
SVRi = 80 ∙ (MAP – CVP) / CI.
Statistical analysis
Guidelines for reporting reliability and agreement studies (Kottner, et al., 2011) suggest, for continuous variables, reliability should be assessed
using intraclass correlation coefficients (ICC) and
agreement using standard errors of measurement
(SEM). Mean values for all variables (i.e., 19 paired
measures) obtained during the final minute of the
rest period and submaximal steady-state exercises (50% and 70% of peak power), were analysed
for intrarater reliability and agreement. During the
high-intensity interval exercise, mean values calculated only for data collected during the 10 intervals
and not the recovery period (i.e., 19 paired measures) were used for analyses. Estimates of reliability (ICC with 95% confidence intervals) and agreement (SEM) were calculated for all the PhysioFlowderived variables during all conditions. Variables
with an ICC greater than 0.75 were considered indicative of good reliability, while those below 0.75
were considered poor to moderately reliable (Portney & Watkins, 2009). MDD using 95% confidence
intervals were calculated according to the following equation: MDD = z ∙ SEM ∙ √2 (Beaten, et al.,
2001; Portney & Watkins, 2009), where z = 1.96
for 95 % confidence intervals. Differences in urine
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specific gravity, oxygen consumption and all the
PhysioFlow-derived variables between trials were
determined using a dependent t-test. All data are
presented as mean ± standard deviation, unless otherwise noted. All statistical analyses were conducted using SPSS (Version 22, IBM®, USA) software,
with significance set at p≤.05.

Results

No differences were observed between trial one
and trial two for urine specific gravity (1.008±0.006
vs. 1.007±0.005; p=.37). Similarly, no differences were observed for oxygen consumption at rest
(0.31±0.06 vs. 0.31±0.08 L∙min-1; p=.92), during
50% steady-state cycling (2.02±0.45 vs. 2.05±0.50
L∙min-1; p=.33), 70% steady-state cycling (2.86±0.67
vs. 2.88±0.70 L∙min-1; p=.56), or during high-intensity interval cycling (1.87±0.46 vs. 1.82±0.46
L∙min-1; p=.24).
The intrarater reliability and agreement of
the PhysioFlow-derived variables for central systolic function (Table 1), central diastolic function
(Table 2) and peripheral vascular function (Table 3)
at rest, during steady-state cycling and interval cycling are presented. HR and LCWi were greater
during the high-intensity interval exercise in trial
one compared with trial two (p=.04 and p=.03, respectively). Additionally, EDV was greater during trial one compared with trial two during rest
(p=.02), 50% steady-state (p=.03), 70% steady-state
(p=.03) and during the high-intensity interval exercise (p=.02). No other significant differences were
observed for any other variables between trial one
compared to trial two.

Discussion and conclusions

The main objective of this study was to determine the intrarater reliability and agreement of all
the PhysioFlow-derived variables at rest, during
submaximal steady-state exercise and high-intensity interval exercise in a healthy population. Additionally, we have calculated MDD for all the variables during each condition to provide researchers
and clinicians with valuable information regarding
the sensitivity of PhysioFlow to detect changes between repeated measures. The variables demonstrating good reliability (ICC>0.75) across exercise
conditions were HR, SV, CO, LCWi and EDV. All
other central and peripheral haemodynamic variables demonstrated suboptimal reliability (ICC<0.75)
during some or all of the rest and exercise conditions.
Central systolic function
The ability to measure HR, SV and CO is important to determine cardiovascular health (Esposito, Mathieu-Costello, Shabetai, Wagner, & Richardson, 2010) as well as monitor cardiovascular stress
143
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Table 1. Intrarater reliability and agreement of central systolic function variables measured or calculated using PhysioFlow at
rest, during steady-state cycling (50% and 70% peak power output) and interval cycling (90% peak power output)
Trial 1
(mean±SD)

Trial 2
(mean±SD)

Difference

ICC
(95% CI’s)

SEM

MDD

Resting

HR
SV
CO
SVi
CI
VET
CTI
EF
LCWi

76±11
88±24
6.57±1.64
47.28±10.32
3.56±0.77
340±53
218±84
72.56±15.51
4.54±1.31

78±12
82±18
6.25±1.13
44.66±8.77
3.53±0.75
352±43
245±67
77.36±9.23
4.24±1.15

1.5±8.0
-5.4±17.2
-0.3±1.1
-2.6±9.1
0.0±0.8
12.2±53.6
27.7±77.6
4.8±15.4
-0.3±0.9

.86 (.63, .95)
.81 (.49, .93)
.81 (.52, .93)
.71 (.23, .89)
.60 (-.04, .85)
.56 (-.15, .83)
.65 (.10, .87)
.43 (-.47, .78)
.84 (.59, .94)

3.01
7.60
0.47
4.94
0.51
35.76
45.78
11.60
0.36

8.35
21.05
1.31
13.70
1.40
99.09
126.87
32.14
0.99

50% steadystate

HR
SV
CO
SVi
CI
VET
CTI
EF
LCWi

142±15
113±27
15.78±3.31
61.00±11.06
8.56±1.38
242±26
376±127
81.20±10.67
12.73±3.24

142±16
109±23
15.29±2.87
59.06±10.06
8.71±2.51
240±29
386±104
84.93±6.75
11.88±2.40

0.3±7.1
-4.1±18.2
-0.5±2.3
-1.9±10.0
0.2±2.1
-2.7±27.9
9.7±126.3
3.7±11.1
-0.9±2.2

.94 (.85, .98)
.85 (.60, .94)
.85 (.60, .94)
.71 (.26, .89)
.62 (.00, .85)
.64 (.07, .86)
.58 (-.36, .84)
.38 (-.61, .76)
.82 (.53, .93)

1.70
7.14
0.91
5.35
1.30
16.72
81.56
8.75
0.94

4.70
19.79
2.51
14.82
3.61
46.33
226.04
24.24
2.59

70% steadystate

HR
SV
CO
SVi
CI
VET
CTI
EF
LCWi

171±13
115±26
19.42±3.93
61.90±9.59
10.51±1.38
215±23
378±90
81.97±8.09
16.17±3.79

171±14
110±22
18.71±3.41
59.81±9.09
10.65±2.87
223±27
390±114
84.54±6.75
15.32±3.03

0.0±6.3
-4.4±13.5
-0.7±2.4
-2.1±7.1
0.1±2.5
7.9±34.2
11.6±71.7
2.6±8.7
-0.8±2.4

.94 (.84, .98)
.91 (.78, .97)
.88 (.70, .96)
.83 (.57, .94)
.56 (-.14, .83)
.17 (-1.15, .68)
.86 (.64, .95)
.48 (-.35, .80)
.86 (.64, .95)

1.54
3.96
0.82
2.90
1.66
31.16
26.64
6.27
0.89

4.28
10.97
2.28
8.04
4.60
86.35
73.82
17.37
2.48

Interval

HR
SV
CO
SVi
CI
VET
CTI
EF
LCWi

152±14*
117±26
17.66±3.75
63.07±9.90
9.54±1.42
218±20
393±108
81.77±7.91
14.70±3.73*

148±14
112±21
16.47±2.99
60.45±8.93
9.30±2.30
221±22
377±101
83.81±6.32
13.40±2.67

-4.0±8.6
-4.6±16.3
-1.2±2.9
-2.6±8.2
-0.2±2.2
2.7±11.6
-15.6±65.6
2.0±8.0
-1.3±2.5

.89 (.86, .92)
.87 (.83, .90)
.79 (.72, .84)
.73 (.64, .80)
.52 (.36, .64)
.61 (.48, .71)
.75 (.67, .811)
.51 (.35, .63)
.82 (.76, .86)

2.83
5.90
1.34
3.48
1.53
7.23
32.87
5.59
1.06

7.83
16.35
3.72
9.64
4.25
20.03
91.08
15.50
2.94

Note. SD: standard deviation; CV: coefficient of variation; ICC: intraclass correlation coefficient; CI: confidence interval; SEM: standard
error of measurement; MDD: minimal detectable difference; HR: heart rate (bpm); SV: stroke volume (mL); CO: cardiac output (L·min1
); SVi: stroke volume index (mL·m2); CI: cardiac index (L·min-1·m2); VET: ventricular ejection time (ms); CTI: contractility index (AU);
EF: ejection fraction (%); LCWi: left cardiac work index (kg·m -1·m2). *trial 1 greater than trial 2 (p≤.05)

Table 2. Intrarater reliability and agreement of central diastolic function variables measured or calculated using PhysioFlow at
rest, during steady-state cycling (50% and 70% peak power output) and interval cycling (90% peak power output)
Trial 1
(mean±SD)

Trial 2
(mean±SD)

Difference

ICC
(95% CI’s)

SEM

MDD

Resting

EDV
EDFR

123.98±32.40*
52.88±10.75

107.67±25.40
49.53±8.50

-16.3±26.3
-3.3±12.0

.74 (.34, .90)
.38 (-.62, .76)

13.31
9.49

36.88
26.29

50% steadystate

EDV
EDFR

139.23±29.17*
58.39±10.26

129.29±30.25
58.48±7.43

-9.9±18.1
0.1±9.3

.90 (.73, .96)
.63 (.03, .86)

5.78
5.68

16.02
15.74

70% steadystate

EDV
EDFR

140.17±29.75*
62.12±14.10

131.80±30.19
59.04±12.23

-8.4±15.0
-3.1±18.4

.93 (.83, .97)
.05 (-1.46, .64)

3.88
17.92

10.76
49.65

Interval

EDV
EDFR

143±30.14*
65.05±9.28

134±29.23
65.48±9.18

-8.9±15.5
0.4±7.4

.91 (.88, .93)
.58 (.44, .68)

4.62
4.81

12.82
13.32

Note. SD: standard deviation; CV: coefficient of variation; ICC: intraclass correlation coefficient; CI: confidence interval; SEM: standard
error of measurement; MDD: minimal detectable difference; EDV: end diastolic volume (mL); EDFR: early diastolic filling ratio (%).
*trial 1 greater than trial 2 (p≤.05)
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Table 3. Intrarater reliability and agreement of peripheral vascular function variables calculated using PhysioFlow at rest, during
steady-state cycling (50% and 70% peak power output) and interval cycling
Trial 1
(mean±SD)

Trial 2
(mean±SD)

Difference

ICC
(95% CI’s)

SEM

MDD

Resting

SVR
SVRi

1182±295
2083±530

1137±142
2069±379

-45.5±262.6
-13.7±655.1

.53 (-.23, .82)
-.02 (-1.65, .61)

181
648

502
1795

50% steadystate

SVR
SVRi

552±87
969±177

552±97
997±215

-0.1±78.0
27.4±218.6

.78 (.43, .92)
.56 (-.16, .83)

37
146

101
404

70% steadystate

SVR
SVRi

460±62
810±139

470±81
852±180

10.0±67.6
42.0±198.2

.72 (.26, .89)
.39 (-.59, .77)

36
155

100
429

Interval

SVR
SVRi

539±128
906±164

555±99
979±186

16.3±140.6
72.9±246.5

.40 (.19, .54)
.46 (.28, .60)

110
181

304
502

Note. SD: standard deviation; CV: coefficient of variation; ICC: intraclass correlation coefficient; CI: confidence interval; SEM: standard
error of measurement; MDD: minimal detectable difference; SVR: systemic vascular resistance (Dyn·s-1·cm5); SVRi: systemic vascular
resistance index (Dyn·s-1·cm5·m2).

during exercise (Fletcher, et al., 2001). Our findings indicate a good level of reliability (ICC>.75)
for these variables, as assessed using the PhysioFlow, at rest and during submaximal steady-state
exercise (Table 1). The level of reliability reported
in this study is consistent with the previous PhysioFlow research (Schultz, et al., 2012; Welsman, et
al., 2005), which has demonstrated good reliability for SV (ICC=.88) and CO (ICC=.86) measured
at peak oxygen consumption during a graded exercise test (Welsman, et al., 2005), as well as good
reliability for HR, SV and CO when measured at
three submaximal steady-state exercise workloads
(40 W, 60% HRmax and 70% HRmax) (Schultz, et
al., 2012). The use of high-intensity interval exercise is a common technique to increase health and
fitness in young (Rakobowchuk, et al., 2008), aging
(Knowles, Herbert, Easton, Sculthorpe, & Grace,
2015) and chronic diseased populations (Wisloff, et
al., 2007). Extending on previous works (Schultz,
et al., 2012; Welsman, et al., 2005), we observed
a good level of reliability for HR (ICC=.89), SV
(ICC=.87) and CO (ICC=.79) during high-intensity
interval exercise. The use of 30-second efforts in
this study did not allow for a physiological steadystate, suggesting that the PhysioFlow is capable of
obtaining reliable measures of HR, SV and CO in
both steady-state and dynamic exercise conditions.
In addition to HR, SV and CO, the PhysioFlow
provides additional central systolic variables, namely CI, SVi, VET, CTI, EF and LCWi (Table 1). Interestingly, only LCWi demonstrated good reliability
across conditions. The use of LCWi as measured
by bioimpedance cardiography has been shown to
distinguish between levels of left ventricular dysfunction during a dobutamine stress test (Leitman,
et al., 2006) and increases in LCWi are consistent
with aerobic exercise training (Jakovljevic, et al.,
2010). These data demonstrate the clinical utility
of measuring LCWi and, in context of our reliability data, suggest this measure would be valuable in
future research investigating the acute and chron-

ic responses of LCWi during exercise. In contrast,
the measurement of EF by bioimpedance cardiography is presented as a time- and cost-efficient alternative to echocardiography in a clinical setting
(Parrott, Burnham, Quale, & Lewis, 2004); however, our results indicate this measure is unreliable.
Our findings are not consistent with previous work
(Schultz, et al., 2012) in which a good level of reliability (ICC=.92 to .97) was observed for the measure of EF using the PhysioFlow at three submaximal steady-state intensities. In the present study,
measures of EF (Table 1) were greater than those
reported by Schultz et al. (2012); thus, it is possible
that the PhysioFlow can provide reliable measures
of EF under a certain threshold (e.g., 61%) and become less reliable at higher values possibly due to
changes in sensitivity of determining VET and PEP
at higher heart rates. Irrespective, previous studies
have observed equivocal results regarding the validity of EF estimated by bioimpedance cardiography devices (Miles, et al., 1990; van der Meer, et
al., 1996). Taken together, these data warrant caution when considering using this measure.
It is important to note that while previous research has compared CI, SVi, VET and CTI between conditions or individuals, the results of the
present study provide further insight into the confidence of these findings. For instance, Vella et al.
(2011) observed 1.1 L∙min-1∙m2 higher CI (measured by PhysioFlow) in obese compared with nonobese adults during steady-state cycle exercise at
65% peak aerobic capacity suggesting excess body
mass is associated with increased cardiac stress
during moderate intensity exercise. However, the
MDD of CI at 50-70% of peak power output within the present study (3.61-4.60 L∙min-1∙m2; Table 1)
indicates this may not be a meaningful difference.
Further, Boutcher et al. (2003) demonstrated greater CI and SVi at rest and in response to exercise in
trained men compared with untrained and sedentary men. VET has been inversely correlated with
aortic pulse wave velocity and thus arterial stiff145
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ness (Salvi, et al., 2013) and positively correlated
with pressure gradients in aortic stenosis (Kadem,
et al., 2002). The 134.6 lower resting CTI in obese
compared with non-obese adults observed by Vella
et al. (2012), is greater than the MDD reported in
the current study (126.9), supporting the conclusion that obese individuals do, indeed, have significantly lower cardiac contractility than non-obese
individuals.
Central diastolic function
Resting and exercise EDV is greater in competitive compared with non-competitive runners
(Crawford, Petru, & Rabinowitz, 1985) as well as
following exercise training interventions (Esfandiari, Sasson, & Goodman, 2014). Our data demonstrate that the PhysioFlow can reliably estimate
EDV at rest and during steady-state and interval
exercise (Table 2) corroborating and expanding on
data from Schultz et al. (2012). Nevertheless, caution should be exercised when using this device
to estimate EDV within certain situations. For instance, our data indicate the PhysioFlow is capable
of detecting differences in resting EDV (43 mL)
between competitive and non-competitive runners
(Crawford, Petru, & Rabinowitz, 1985) as they are
beyond the calculated MDD at rest (Table 2; 36.88
mL); however, changes in submaximal EDV (12
mL) reported after a short-term high-intensity interval training program (Esfandiari, Sasson, & Goodman, 2014) are likely too small (MDD = 16.02 mL)
to be considered a true effect when using this device. Bioimpedance-derived EDFR is analogous
with the Doppler echocardiography-derived E/A
ratio, a measure of diastolic function dependent on
preload (Pickett & Buell, 1993). Indeed, E/A ratio
is inversely correlated with age, blood pressure and
aerobic capacity (Missault, et al., 1993). Given diastolic function is multifactorial (Little & Downes,
1990), it is unlikely this measure alone is of any
clinical relevance; however, when combined with
Doppler echocardiography, it may provide useful
information regarding central diastolic function
(Pickett & Buell, 1993).
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Peripheral vascular function
Systemic vascular resistance and SVRi estimated by bioimpedance cardiography have been used
to assess cardiovascular responses to various physiological stimuli (Bogaard, et al., 1997; Freimark, et
al., 2007; Ouzounian, Masaki, Abboud, & Greenspoon, 1996; Tahvanainen, et al., 2011; Tahvanainen, Leskinen, Koskela, Ilveskoski, Alanko, et al.,
2009; Tahvanainen, Leskinen, Koskela, Ilveskoski,
Nordhausen, et al., 2009). Although demonstrating
the clinical utility of measuring SVR and SVRi,
these studies did not use the PhysioFlow device. Our
results demonstrate that SVRi is temporally unreliable at rest and during exercise, while SVR demonstrated moderate to good reliability during steadystate exercise and suboptimal reliability at rest and
during high-intensity interval exercise (Table 3).
Our results are comparable with those reported by
Schultz et al. (2012) who demonstrated moderate
to good reliability of SVR during steady-state exercise. Consequently, researchers and clinicians
should acknowledge this limitation when considering the use of these variables. It should be noted that
the participants in the current study were healthy
and had normal BMI. It is possible that the findings
outlined in this study are not representative of other
populations, such as overweight and obese. However, haemodynamic changes assessed by bioimpedance cardiography have previously been validated
in obese individuals (Brown, et al., 2005; Richard,
et al., 2001), patients with chronic obstructive pulmonary disease and hyperinflation (Bougault, et al.,
2005), and pregnant populations (San-Frutos, et al.,
2011), suggesting bioimpedance cardiography can
be used across various body habitus.
Our results indicate that HR, SV, CO, LCWi
and EDV demonstrated a level of reliability acceptable for use regardless of exercise type (continuous
vs. interval) or intensity (low, moderate or high).
Careful consideration should be given to the use
of all other variables. Minimal detectable differences for all variables during rest and exercise were
also provided to demonstrate the sensitivity of the
PhysioFlow device.
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